A Study to Evaluate the Exposure of Norelgestromin and Ethinyl Estradiol From Commercial Lots of EVRA (a Transdermal Contraceptive Patch Manufactured by LOHMANN Therapie-Systeme) and CILEST (an Oral Contraceptive)
PHASE1
The objective of this study is to estimate exposure to the hormones norelge...
Relative Risks for Non-fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction in Users of ORTHO EVRA(Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared to Levonorgestrel-containing Oral Contraceptives.
N/A
This study uses the PharMetrics and MarketScan US health care insurance cla...
Status
Completed
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT00511784
Birth Control Pill vs Birth Control Patch Study
NA
This study was a randomized, investigator-blinded, cross-over, clinic trial...
Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks
N/A
The purpose of the study is to assess the occurrence of venous thromboembol...